Germline mutations in the BRCA1 and BRCA2 genes are responsible for the predisposition and development of familial breast and/or ovarian cancer. Most mutations of BRCA1 and BRCA2 associated with breast and/or ovarian cancer result in truncated proteins. To investigate the presence of BRCA1 and BRCA2
Significant proportion of breast and/or ovarian cancer families of French Canadian descent harbor 1 of 5 BRCA1 and BRCA2 mutations
✍ Scribed by Kathleen K. Oros; Parviz Ghadirian; Celia M.T Greenwood; Chantal Perret; Zhen Shen; Yosabeth Paredes; Suzanna L. Arcand; Anne-Marie Mes-Masson; Steven A. Narod; William D. Foulkes; Diane Provencher; Patricia N. Tonin
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- French
- Weight
- 193 KB
- Volume
- 112
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
In 1998, we reported that a significant proportion of breast and/or ovarian cancer families of French Canadian descent harbor specific germline mutations in BRCA1 or BRCA2 attributed to common founders. Here we report the frequency of previously described mutations (n = 7) and 13 mutations identified in French Canadian families since 1998, in a new group of families (n = 88). Four of the previously described mutations, 4446C>T, 2953delGTAinsC, 8765delAG and 6085C>T, account for 72% and 69% of mutation‐positive families in previously (n = 81) and recently ascertained groups, respectively. Only 2 of 13 recently identified mutations were found in more than 1 family: 3875delGTCT (n = 2) and 3398delAAAAG (n = 4). The 2 groups (ascertained pre‐ and post‐gene discovery) did not differ significantly when distribution of mutations based on cancer syndrome phenotype and age of diagnosis or number of breast cancer cases were compared. Five common mutations accounted for a significant proportion (84%) of all mutation‐positive families. The age of diagnosis of female breast cancer in mutation‐negative families was significantly higher than that of the mutation‐positive families (p<0.0001). The total number of cases of cancer per family was significantly lower in mutation‐negative than mutation‐positive families (p<0.001). Our results define a new mutation panel for screening BRCA1/2 mutations and the phenotype of mutation‐positive families harboring the common mutations in the French Canadian population. © 2004 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Among Asian countries, Pakistan has the highest rates of breast and ovarian cancer. To assess the contribution of the __BRCA1__ and __BRCA2__ germ line mutations to these high rates, we conducted the first study of 176 Pakistani breast and ovarian cancer patients, selected on family his